Altshuler Shaham LTD Cyma Bay Therapeutics, Inc. Transaction History

Altshuler Shaham LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$1.41 - $4.25 $93,624 - $282,200	-66,400 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$1.25 - $2.02 $34,286 - $55,406	-27,429 Reduced 29.23%	66,400 $98,000
Q3 2019 Nov 12, 2019	BUY	$5.12 - $7.21 $6,097 - $8,587	1,191 Added 1.29%	93,829 $474,000
Q2 2019 Aug 06, 2019	BUY	$6.05 - $13.66 $30,631 - $69,160	5,063 Added 5.78%	92,638 $663,000
Q4 2018 Feb 11, 2019	SELL	$6.54 - $11.74 $2,825 - $5,071	-432 Reduced 0.49%	87,575 $689,000
Q2 2018 Aug 13, 2018	BUY	$10.66 - $14.38 $294,216 - $396,888	27,600 Added 45.69%	88,007 $1.18 Million
Q1 2018 May 15, 2018	SELL	$9.0 - $15.16 $39,537 - $66,597	-4,393 Reduced 6.78%	60,407 $785,000
Q4 2017 May 14, 2018	BUY	$7.67 - $9.31 $497,016 - $603,288	64,800	64,800 $596,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.